Purpose: Intensity-modulated radiation therapy (IMRT) utilizes many small fields for producing a uniform dose distribution. Therefore, there are many field junctions in the target region, and resulting dose uncertainties are accumulated. However, such accumulation of the dose uncertainty has not been implemented in the current practice of IMRT dose verification. The purpose of this study is to develop a method to predict the gamma passing rate (GPR) using a dose uncertainty accumulation model. Methods: Thirty-three intensity-modulated (IM) beams for head-and-neck cases with step-and-shoot techniques were used in this study. The treatment plan was created using the XiO treatment planning system (TPS). The IM beam was produced by the ONCOR Impression Plus linear accelerator. Map-CHECK was used to measure the dose distribution. The distribution of a dose uncertainty potential (DUP) was generated by in-house software that accumulated field shapes weighted by a segmental monitor unit, followed by Gaussian folding. The width of the Gaussian was determined from the width of the lateral penumbra. The dose difference between the calculated and measured doses was compared with the estimated DUP at each point. The GPR of each beam was predicted for 2%/2-mm, 3%/2-mm, and 3%/3-mm tolerances by its own DUP histogram and a GPR-vs-DUP correlation of other beams using the leave-one-out cross-validation method. The predicted GPR was compared with the measured GPR to evaluate the performance of this prediction method. The criteria for the predicted GPR corresponding to a measured GPR ≥ 90% were estimated to examine the feasibility of estimating the measured GPR by this GPR prediction method. Results: The DUP was confirmed to have proportionality to the standard deviation (SD) of the dose difference. The SDs of the difference between the measured and predicted GPRs were 3.1, 1.7, and 1.4% for 2%/2-mm, 3%/2-mm, and 3%/3-mm tolerances, respectively. The criteria of the predicted GPR corresponding to the measured GPR ≥ 90% were 94.1 and 95.0% with confidence levels of 99 and 99.9%, respectively. Conclusion: In this study, we confirmed the good proportionality between the dose difference and the estimated DUP. The results showed a feasibility to predict the dose difference from DUP as estimated by a DUP accumulation model. The predicted GPR developed in this study showed good accuracy for planar dose distributions of head and neck IMRT. The prediction method developed in this study is considered to be feasible as a substitute for the current practice of measurement-based verification of the dose distribution with gamma analysis.
INTRODUCTION
Intensity-modulated radiation therapy (IMRT) produces homogeneous dose distributions with a wide variety of complex shapes of prescribed doses to the target volume. The delivery of IMRT is typically verified by irradiating the intensity-modulated (IM) beam to some patient-specific quality assurance (QA) device in order to compare the calculated and measured dose distributions. A comparison of two dose distributions is typically evaluated by gamma analysis in clinical QA practice. 1, 2 The advantage of the gamma analysis is that the region with a steep dose gradient in the composite distribution is taken into account.
Generally, the junction between treatment fields requires special attention since the dose uncertainty (DU) around the junction is the largest in the target volume. It is well known that the moving junction reduces the DU around the patching region in three-dimensional (3D) conformal radiation therapy such as craniospinal irradiation or multiport breast radiation therapy. The major concern in this 3D case is the dose error caused by the setup error. A similar concern with DU around the field junction remains in IMRT because it involves many field junctions that are buried in the composite dose distribution. The agreement between the calculated and measured dose distributions depends on the quality of the beam model in the TPS. The discrepancy of the penumbra shape and position at each control point is accumulated in the composite dose distribution. Therefore, the spatial distribution of the field junctions is considered to have large uncertainty potential even though the setup of the QA device is static.
The paradigm of dose uncertainty prediction using both accumulation history and dose gradient was first proposed by Kim et al. 3 and further developed by Jin et al. 4, 5 Their concept of nonspatial and spatial DUs by taking all control points into account for calculating the composite DU 4, 5 was successfully applied to clinical cases. 6 The spatial DU distribution is inhomogeneous and depends on the type of IM, such as step-andshoot or sliding window. A gamma analysis is typically applied to the dose distribution of an IM beam involving all control points, or to a composite dose distribution by all IM beams in a fraction. Therefore, the inhomogeneity of the DU distribution is not taken into account in the gamma analysis.
Substitute methods for patient-specific QA are becoming important in improving the process of the treatment preparation of IMRT. By substituting some calculations for the patient-specific QA measurement and the gamma analysis, the time and cost are expected to decrease during IMRT preparation. Specifically, the correlation of the substitute with the gamma passing rate (GPR) is examined in order to maintain the criteria of current clinical QA practice. Complexity metrics of IMRT were proposed and investigated by several authors in recent years. [7] [8] [9] [10] [11] [12] [13] [14] The modulation complexity score (MCS) developed by McNiven et al. 7 characterizes the average plan complexity using the beam parameters of leaf positions, degree of irregularity in the field shape, segment weight, and area. The researchers investigated the correlation between the MCS and the delivered dose measured by a twodimensional (2D) diode array in terms of beam parameters such as the number of segments and monitor units (MUs). Other authors reported correlations between the MCS and GPR in volumetric-modulated arc therapy (VMAT). [8] [9] [10] [11] Although there are various other approaches, [12] [13] [14] there is no satisfactory technique to substitute for the gamma analysis.
To develop a substitute method for gamma analysis, it was inferred that the dose uncertainty potential (DUP) introduced by Kim et al. 3 could predict the GPR. The purpose of this study was to develop a method to predict the GPR using data of the DUP distribution. In this study, a model was created to predict the GPR using the DUP data and its performance was evaluated. The evaluation of the GPR prediction was performed for the tolerances of 3%/3 mm, 3%/2 mm, and 2%/ 2 mm. The 3%/2-mm tolerance was involved since it was recently recommended in the AAPM TG-218 report. 15 
MATERIALS AND METHODS

2.
A. Clinical equipment, treatment plans, and patient-specific verification data A schematic diagram of the data flow for predicting the GPR is shown in Fig. 1 . The treatment plans were created using XiO TPS (Elekta AB, Stockholm, Sweden) with a beam model for the ONCOR Impression Plus linear accelerator (Siemens Medical Systems, Concord, CA). Thirty-three IM beams were used to develop our algorithm for predicting the GPR. All beams were step-and-shoot with a 6-MV beam energy. The treatment plan parameters were exported from TPS to the linear accelerator and to the DUP generator described in Section 2.B in the format of digital imaging and communications in medicine (DICOM).
The planar dose distribution was calculated with a 2-mm grid size and was linearly interpolated with a 1-mm grid size. The calculated planar dose distribution (D calc ) was exported from TPS to our in-house GPR analyzer (described in Section 2.D) through the MapCHECK software (Sun Nuclear, Melbourne, FL). The MapCHECK device was used to measure the planar dose distribution of the IM beams with the gantry angle overridden to 0°. The MapCHECK device had silicon diode detectors (0.8 mm / ) arranged in an octagonal grid of 22 cm. The detectors in a 10 9 10-cm 2 region were arranged in 7-mm intervals, while others outside this region were arranged in 14-mm intervals. The 2D dose distribution for each beam was measured with the gantry angle overridden to 0°. The source-to-detector distance was 100 cm.
The measured planar dose distribution (D meas ) was created from the measured dose at each detector element by a 2D interpolation with a 1-mm grid size. D meas and D calc were exported to the GPR analyzer in text format. The DUP generator produced DUP distributions in a 1-mm grid size based on the DUP accumulation model described in Section 2.B. The DUP data were exported to the GPR analyzer in order to investigate the dose difference and GPR in comparison with the DUP, the details of which follow in Section 2.D.
2.B. Dose uncertainty potential distribution
The DUP distribution was generated by our in-house DUP generator written in Python. Figures 2(a) and 2(b) show a lateral dose profile D(r) and the absolute value of the dose gradient |dD(r)/dr|, respectively. In this study, the DUP for a field edge (FE) of each control point was assumed to be proportional to |dD(r)/dr| [ Fig. 2(b) ] and a monitor unit (MU) of the control point. The dose gradient was approximated by a Gaussian distribution. Since a DUP far from the FE is negligibly small for a beam with a flattening filter, we only analyzed the DUP around FE.
The coordinates of multileaf collimator (MLC) were extracted from the DICOM RT Plan to create the FE of each control point. The definitions of the coordinate system on the beam's-eye view (BEV) are shown in Fig. 2 . The accumulated FE distribution was then folded by a 2D Gaussian with standard deviations (SDs) in the crossline and the inline. The accumulated and folded FE distribution was used as a DUP distribution in this study. The DUP at r * BEV on the BEV is given by uð r
where r C and r I are SDs for the directions of the crossline and inline, respectively, as shown in Fig. 2(d) . The SDs were determined from the crossline and inline profiles of the MLC field. OAR is the off-axis ratio as a function of the distance between the point of interest ( r * i FE ) and the central axis. The suffix i CP runs over all control points of the IM beam, and i FE runs over all the pixels on the FE. These SDs were determined to be 3.9 mm for both r C a r I , which reproduced the full width at half maximum of the gradient of the crossline and inline profiles with the collimator at 0°, respectively [ Fig. 2(b) ]. The DUP distribution was used to evaluate the dose difference and to predict the GPR, as described in the following sections. 
2.D. Predicting gamma passing rate
A diagram for the calculation of the predicted GPR (pGPR) is shown in Fig. 3 . Each data item had 2D distributions of D calc from TPS, D meas and c from MapCHECK, and DUP from the DUP generator. The c distribution was calculated with 2%/2-mm, 3%/2-mm, and 3%/3-mm tolerances. The measured GPR of the evaluated beam [mGPR i Eval ] was calculated from the c distribution [ Fig. 3(a) ] using
where D max calc is the maximum dose in the D calc distribution and N is the number of pixels that passed the criteria in parentheses (Step #1).
The DUP distribution [ Fig. 3(b) ] was converted to a histogram of the DUP [ Fig. 3(c) ] of the evaluated beam (Step #2). This histogram was considered to be a characteristic that had some relationship with the dose accuracy such as the dose difference and GPR. The explicit expression of the DUP frequency of the evaluated beam f i Eval ðu j Þ Â Ã is written as
where u is the DUP, j is a suffix for the DUP bin, and u j = j 9 0.2 (j ¼ 0; 1; Á Á Á). 
where i is the beam ID. The average of mGPR i u j À Á
[aGPR u j À Á , Fig. 3(g) ] was calculated for the learning data: 
Step #3). Namely, aGPR u j À Á is an average of mGPR for a specific DUP bin. The aGPR curve was involved in predicting GPR.
The predicted GPR (pGPR) for the evaluated beam was calculated by
where f i Eval u j À Á is the frequency in the jth DUP bin of the evaluated beam (Step #4). The suffix j runs over the entire range of DUP. Namely, pGPR i Eval is a mean of aGPR u j À Á weighted by f i Eval u j À Á , which is the characteristic of the evaluated beam. The calculated pGPR was then compared with mGPR for each evaluated beam by a leave-one-out cross-validation in order to evaluate the performance of this method to predict the GPR (Step #5).
A correlation between pGPR and mGPR was analyzed with multiple tolerances for the c analysis. The precision of pGPR was evaluated by the SDs of the difference between pGPR and mGPR for each pGPR bin. The criteria for pGPR corresponding to the clinical mGPR ≥ 90% criterion were investigated for different confidence levels (CLs). The lower limit of pGPR (pGPR LL ) was estimated using the SD for confidence levels (CLs) of 99% and 99.9%:
with n = 2.3 and 3.1 corresponding to a CL of 99% and 99.9%, respectively.
RESULTS
Figure 4(a) shows a scatter plot of DD vs DUP, which is the same result as the previous work by Jin et al. 5 , but we kept the sign of DD. The SD of DD at each DUP was calculated [ Fig. 4(b) ]. It was confirmed that the SD (DD) had good proportionality with the DUP; thus, the accumulated DUP was a good complexity metric for evaluating the dose agreements in QA evaluations. Figure 5 (a) shows the correlations between mGPR and pGPR. Red triangles, blue circles, and green plus symbols show the data for 2%/2-mm, 3%/2-mm, and 3%/3-mm tolerances, respectively. Figure 5(b) shows the difference between pGPR and mGPR as a function of pGPR. The average SDs for 2%/2-mm, 3%/2-mm, and 3%/3-mm tolerances were 3.1, 1.7, and 1.4%, respectively. The SD of the subtraction of mGPR and pGPR is shown in Fig. 6(a) as a function of pGPR. Figure 6 (b) shows the lower limit defined by Eq. (7) as a function of pGPR. Green open squares and red open circles show the data for CL = 99% and 99.9%, respectively. The intersection of pGPR LL = 90% corresponds to the lower limit of pGPR for the mGPR ≥ 90% criterion in the current measurement-based verification of the gamma analysis. The lower limits of the pGPR values for 99% and 99.9% CLs were 94.1% and 95.0%, respectively.
DISCUSSION
In this study, we investigated the dose difference together with the accumulated DUP. A proportional relationship between the dose difference and DUP was confirmed, in agreement with the previous study by Jin et al. [4] [5] [6] The results showed the possibility of predicting the dose difference from the DUP estimated by the DUP accumulation model. The method developed in this study showed that the prediction accuracy [SD (pGPR À mGPR)] of GPR for the 3%/3-mm tolerance was 1.4%. Among the IM beams investigated in this study, 1 beam out of 33 beams had lower pGPR than the 99.9% CL lower limit (95.0%). Therefore, the method of predicting the GPR using the DUP was a successful substitute for patient-specific QA measurements using the gamma analysis for 32 beams in this study. The accurate prediction of the GPR is possible in advance, and replanning can be conducted if pGPR is too low. Thus, this technique is expected to help reduce the time and cost of replanning, preparing the verification, performing the verification measurement (which creates extra occupancy of the treatment machine), and the following analysis.
We simply adopted the SD of the difference between pGPR and mGPR, while previous studies employed Pearson's correlation coefficient r to evaluate the proportionality of the complexity metric with the GPR. [10] [11] [12] 14 Pearson's r depends on the range of parameters investigated as well as the proportionality of the investigated parameters. Namely, a wide range of GPR values results in a large r value. In addition, since our method provided a prediction of the measured GPR, the correlation coefficient was not necessarily used in our evaluation.
Several complexity metrics were investigated in previous studies. The MCS developed by McNiven et al. 7 has been evaluated by many authors. [8] [9] [10] 14 Total leaf travel was also proposed as a complexity metric with a limited correlation to the GPR. 8 The monitor unit was also investigated as a complexity metric, and its proportionality to the GPR was analyzed. 8, 9, 13, 14 These complexity metrics are a single average value created from the beam parameters. In contrast to these complexity metrics, our method is based on the ab initio approach using the spatial DU developed by Jin et al. 4, 5 The c value at each point is considered to depend on each segmental dose delivered to the point. Thus, it is considered advantageous to estimate the GPR based on the property of the delivered dose to each point, which affects the resulting GPR value. We focused on the proportionality of DD to the DUP, which was expected to be a good parameter to estimate the GPR.
The method of predicting the GPR developed in this study used only the DUP distribution assuming a Gaussian distribution around the FE. In practice, the GPR depends on the quality of beam modeling of TPS, the dose calculation algorithm, type of linear accelerator and MLC, measurement accuracy of the QA device, etc. It is considered that the predictive accuracy of the GPR may also depend on such parameters. Thus, the model should be customized for each combination of software and hardware used for the IMRT QA. In particular, the GPR and its prediction depend strongly on the quality of the beam model for the small field created by the MLC. Therefore, the predictive performance of the GPR is expected to improve by taking parameters related to the small field into account. Though the step-and-shoot IM fields were used in this study, this method should also apply to other IM fields such as the sliding window. Furthermore, by extending this model to the 3D space, this method is expected to be applicable to VMAT. Among the prospects for GPR estimation, application to 3D dose distribution has been quite important in recent clinical QA practice as VMAT has been replacing other existing IMRT techniques in recent years.
CONCLUSION
We developed a novel method to predict GPR using the DUP distribution, and demonstrated its performance in this study. It was confirmed that the DUP-based method can provide accurate GPR prediction for the planar dose verification of step-and-shoot IMRT. Thus, this method can provide a proactive estimation of the plan complexity prior to the verification measurement of the IMRT dose delivery.
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